You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematopoietic Stem Cells (HSC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Dresden, Heidelberg (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion
  • Gemtuzumab Ozogamicin
  • Dresden, Germany
  • +1 more
Dec 20, 2022

Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,

Recruiting
  • Diffuse Intrinsic Pontine Glioma (DIPG)
  • Brain Stem Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +5 more
  • Gainesville, Florida
    UF Health Shands Children's Hospital
Apr 29, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +11 more
  • Aldesleukin
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 13, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

Recruiting
  • Granuloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Sickle Cell Disease Trial in Los Angeles, Boston (single infusion of autologous bone marrow derived CD34+ HSC cells transduced

    Active, not recruiting
    • Sickle Cell Disease
    • single infusion of autologous bone marrow derived CD34+ HSC cells transduced with the lentiviral vector containing a short-hairpin RNA targeting BCL11a
    • Los Angeles, California
    • +1 more
    Feb 8, 2022

    Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

    Completed
    Has Results
    • Multiple Myeloma
    • Stanford, California
      Stanford University
    Aug 17, 2022

    Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

    Not yet recruiting
    • Blood Disease
    • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
    • CliniMACS® System
    • (no location specified)
    Jan 30, 2023

    Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)

    Not yet recruiting
    • Glioblastoma
    • 18F-GE-180 PET
    • +4 more
    • Rozzano, (mi), Italy
      IRCCS Istituto Clinico Humanitas
    Oct 27, 2023

    Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

    Not yet recruiting
    • Sickle Cell Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 8, 2022

    Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

    Not yet recruiting
    • Cytomegaloviral Infection
    • Hematopoietic and Lymphoid System Neoplasm
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 16, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
    • +1 more
    Sep 22, 2023

    Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)

    Recruiting
    • Sickle Cell Disease
    • OTQ923
    • Los Angeles, California
    • +4 more
    Jan 9, 2023

    Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

    Terminated
    • Leukemia, Myeloid, Acute
    • +8 more
    • Mesenchymal stem cells
    • Isotonic solution
    • Edeghem, Antwerpen, Belgium
    • +9 more
    Aug 31, 2021

    ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

    Recruiting
    • β-thalassemia
    • β-globin restored autologous hematopoietic stem cells
    • Shenzhen, Guangdong, China
      Shenzhen Children's Hospital
    Feb 24, 2023

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023

    ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

    Recruiting
    • β-thalassemia
    • β-globin restored autologous hematopoietic stem cells
    • Shenzhen, Guangdong, China
      Shenzhen University General Hospital
    May 8, 2023

    a-thalassemia Trial in Nanning (a-globin restored autologous hematopoietic stem cells)

    Recruiting
    • α-thalassemia
    • α-globin restored autologous hematopoietic stem cells
    • Nanning, Guangxi, China
      PLA Joint Logistic Support Force No. 923 Hospital
    May 6, 2023

    Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

    Recruiting
    • Multiple Myeloma
    • Total Marrow irradiation，TMI
    • Autologous hematopoietic stem cell transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 24, 2023

    CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

    Not yet recruiting
    • CMV Infection
    • +2 more
    • Virus specific T cells
    • (no location specified)
    Oct 4, 2023

    Malignant Hemopathy Trial in Saint-Etienne (Blood samples)

    Not yet recruiting
    • Malignant Hemopathy
    • Blood samples
    • Saint-Etienne, France
      CHU de Saint-Etienne
    Feb 7, 2022

    ß-thalassemia Trial (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • (no location specified)
    Mar 15, 2023

    Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)

    Recruiting
    • Lymphoma
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Aug 31, 2023

    ß-thalassemia Trial in Shanghai (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • Shanghai, China
      Shanghai Ruijin Hospital
    Mar 16, 2023

    (LTFU) of Patients Treated With Genome-edited Autologous

    Not yet recruiting
    • Sickle Cell Disease
    • OTQ923
    • (no location specified)
    Nov 24, 2023